IBM scientists have unveiled the world’s smallest movie, made with one of the tiniest elements in the universe: atoms. Named A Boy and His Atom, the Guinness World Records-verified movie used thousands of precisely placed atoms to create nearly 250 frames of stop-motion action. [ + ]

New ASX disclosure guidelines on monitoring social media for leaks of market-sensitive information herald a new era of reporting compliance, according to Buchan Consulting. [ + ]

One of Australia’s premier research facilities, the newly refurbished La Trobe Institute for Molecular Science, has installed an extensive range of Enware safety, laboratory and specialist plumbing solutions into its teaching, research and laboratory facilities. [ + ]

Revenue from the world’s major biotech markets grew 8% in 2012, but weak R&D spending growth is a sign that the sector has still not fully recovered from the GFC, says Ernst & Young. [ + ]

Alimera has launched Iluvien, the intravitreal implant designed by pSivida (ASX:PVA), into the UK market. [ + ]

Australia’s position in the Asia-Pacific region, in what has been dubbed the Asian Century, means biotechnology is poised in the right industry in the right region. [ + ]

Dr Robin Hobbs got off to a stellar start with a breakthrough finding published in Nature. Now he’s continuing to investigate a delicate balancing act that occurs within stem cells in the testis. [ + ]

An organic fertiliser manufacturer has selected Michell Instruments’ XZR500 to monitor oxygen levels in its composting process. The innovative process dramatically reduces the time taken to break down animal dung into a useable form and the XZR500 forms part of the control system. [ + ]

Wyatt Technology is pleased to report the success of the Calypso composition-gradient multi-angle light scattering (CG-MALS) system in a study conducted by the Molecular Interactions Research Group (MIRG) of the Association of Biomolecular Research Facilities (ABRF). [ + ]

Specialised Therapeutics Australia has won approval to market fidaxomicin - the C. difficile treatment licensed from Optimer Pharmaceuticals - in Australia. [ + ]

Through the national network for metabolite analysis and identification, Metabolomics Australia, Murdoch University’s Separation Science and Metabolomics Laboratory recently received $1 million for infrastructure and equipment. [ + ]

Pharmaxis (ASX:PXS) has revealed a phase III trial of Bronchitol in bronchiectasis failed to meet its primary goal, sending its share price falling 45%. [ + ]

A custom-built programmable 3D printer, created by Oxford University scientists, can create materials with several of the properties of living tissues. The material consists of thousands of connected water droplets, encapsulated within lipid films, which can perform some of the functions of the cells inside our bodies. [ + ]

Mesoblast (ASX:MSB) has completed a six-month follow-up from a phase II trial of its adult stem cells in intervertebral disc repair, revealing encouraging interim results. [ + ]

Associate Professor Ruth Arkell is revealing the mysteries of the ZIC family of genes, which have been coordinating the development of the nervous system in vertebrate embryos for hundreds of millions of years. [ + ]